In addition, this miRNA downstream target NCAPH can compete with Akt1 to form a complex with β-catenin, which prevents β-catenin phosphorylation and ubiquitin interceded protein destruction, resulting in triggered Wnt signaling and a more favorable niche for cancer stem cells in NSCLC [84]. This evidence concerns the gene AKT1 and cancer.